Background Monitoring the adaptive immune responses during the natural course of severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection provides useful …

With the recent approval of highly effective coronavirus disease 2019 (COVID-19) vaccines,
functional and lasting immunity to severe acute respiratory syndrome coronavirus 2 (SARS …

Background The duration of humoral and T and B cell response after the infection of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unclear. Methods We …

Objectives Humoral and cellular immunity to SARS‐CoV‐2 following COVID‐19 will likely
contribute to protection from reinfection or severe disease. It is therefore important to …

Objectives This study aimed to explore the severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2)‐specific humoral responses and T‐cell responses in patients who have …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), emerged in late 2019 and has since become a …

Information concerning the longevity of immunity to SARS-CoV-2 following natural infection
may have considerable implications for durability of immunity induced by vaccines. Here, we …

Abstract Background The SARS-CoV-2 pandemic currently prevails worldwide. To
understand the immunological signature of SARS-CoV-2 infections and aid the search and …

The ongoing pandemic of Coronavirus disease 19 (COVID-19) is caused by a newly
discovered β Coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS …

Background The COVID-19 pandemic caused by SARS-CoV-2 coronavirus threatens global
public health. Currently, neutralizing antibodies (NAbs) versus this virus are expected to …